These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15786392)
21. Allograft diabetic nephropathy may progress to end-stage renal disease. Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161 [TBL] [Abstract][Full Text] [Related]
22. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus. Araki S; Haneda M; Koya D; Kashiwagi A; Uzu T; Kikkawa R Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S54-8. PubMed ID: 18947896 [TBL] [Abstract][Full Text] [Related]
23. The discovery of diabetic nephropathy: from small print to centre stage. Cameron JS J Nephrol; 2006; 19 Suppl 10():S75-87. PubMed ID: 16874718 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]
25. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388 [TBL] [Abstract][Full Text] [Related]
26. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Costacou T; Ellis D; Fried L; Orchard TJ Am J Kidney Dis; 2007 Nov; 50(5):721-32. PubMed ID: 17954285 [TBL] [Abstract][Full Text] [Related]
27. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up. Murussi M; Gross JL; Silveiro SP J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471 [TBL] [Abstract][Full Text] [Related]
28. Role of GFR estimation in assessment of the status of nephropathy in type 2 diabetes mellitus. Banerjee S; Ghosh US; Saha SJ J Assoc Physicians India; 2005 Mar; 53():181-4. PubMed ID: 15926598 [TBL] [Abstract][Full Text] [Related]
29. Diabetic nephropathy: a frontier for personalized medicine. Susztak K; Böttinger EP J Am Soc Nephrol; 2006 Feb; 17(2):361-7. PubMed ID: 16407421 [TBL] [Abstract][Full Text] [Related]
30. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy. Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929 [TBL] [Abstract][Full Text] [Related]
31. Preventing microalbuminuria in patients with type 2 diabetes. Jermendy G; Ruggenenti P Diabetes Metab Res Rev; 2007 Feb; 23(2):100-10. PubMed ID: 17094161 [TBL] [Abstract][Full Text] [Related]
32. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632 [TBL] [Abstract][Full Text] [Related]